BridgeBio Oncology Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBOT and other ETFs, options, and stocks.About BBOT
Bridgebio Oncology Therapeutics, Inc. engages in developing bioavailable small molecule inhibitors. It focuses on advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies.
BBOT Key Statistics
Stock Snapshot
As of today, BridgeBio Oncology Therapeutics(BBOT) shares are valued at $2.25. The company's market cap stands at 179.99M.
During the trading session on 2026-11-06, BridgeBio Oncology Therapeutics(BBOT) shares reached a daily high of $2.25 and a low of $2.15. At a current price of $2.25, the stock is +4.4% higher than the low and still 0.0% under the high.
Trading volume for BridgeBio Oncology Therapeutics(BBOT) stock has reached 75.21K, versus its average volume of 648.19K.
The stock's 52-week range extends from a low of $2.07 to a high of $14.87.
The stock's 52-week range extends from a low of $2.07 to a high of $14.87.
Analyst ratings
100%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.